Encompass Health Corporation announced robust financial results for the fourth quarter ended December 31, 2025, demonstrating strong growth across key metrics. Net operating revenue increased by 9.9% to $1,544.6 million, while adjusted EBITDA grew by 15.9% to $335.6 million. Diluted earnings per share from continuing operations rose by 20.3% to $1.42, and adjusted earnings per share saw a 24.8% increase to $1.46. The company also reported a substantial increase in cash flows provided by operating activities, up 24.1% to $346.0 million, and adjusted free cash flow, up 23.6% to $235.4 million. Discharges increased by 5.3%, with same-store discharge growth at 3.2%, and net patient revenue per discharge grew by 4.1%.

Encompass Health demonstrated strong performance in the third quarter of 2025, with net operating revenue increasing by 9.4% to $1,477.5 million and diluted EPS from continuing operations rising by 15.9% to $1.24. Adjusted EBITDA also saw an impressive 11.4% growth, reaching $300.1 million. The company further expanded its capacity by opening three new hospitals and adding 39 beds to existing facilities, and increased its full-year guidance.

Encompass Health demonstrated strong performance in Q2 2025 with a 12.0% increase in net operating revenue to $1,457.7 million and a 23.9% rise in diluted EPS to $1.40. The company's growth was driven by increased discharges and improved pricing, leading to a 17.2% increase in Adjusted EBITDA and a 30.5% increase in Adjusted Free Cash Flow.

The company posted robust revenue and EPS growth, with net income rising significantly year-over-year. Expanded capacity and efficient operations supported performance.

Encompass Health reported strong Q4 2024 results, driven by a 12.7% increase in revenue and a 13.6% rise in Adjusted EBITDA. The company's discharge growth of 7.8% was a key driver of revenue expansion. Net income also saw a significant rise compared to the prior year.

Encompass Health Corporation reported strong results for the third quarter ended September 30, 2024. Revenue increased by 11.9% and Adjusted EBITDA increased by 13.4%. The company also increased its full-year guidance.

Encompass Health reported a strong second quarter with a 9.6% increase in revenue and an 8.9% increase in Adjusted EBITDA, driven by discharge growth. The company added 194 beds to its capacity and resumed share repurchases. Full-year guidance was increased.

Encompass Health reported a strong first quarter with a 13.4% increase in revenue, driven by a 10.0% increase in discharges. Adjusted EBITDA grew by 19.2%, and the company increased its full-year guidance.

Encompass Health reported a strong fourth quarter with a 9.6% increase in net operating revenue and Adjusted EBITDA. The company's discharge growth and net revenue per discharge contributed to the overall revenue increase. Encompass Health provided guidance for 2024, projecting net operating revenue between $5.2 billion and $5.3 billion and adjusted earnings per share between $3.77 and $4.06.

Encompass Health reported a strong third quarter with a 10.8% increase in revenue, driven by discharge growth. Adjusted EBITDA grew by 21.6% due to increased revenue and improved labor costs. The company updated its full-year guidance to reflect these results and expectations for the remainder of the year.

Encompass Health reported strong Q2 2023 results with a 9.8% increase in total discharges and a 27.1% growth in Adjusted EBITDA. The company has increased its full-year guidance to reflect the strong first half results and updated expectations for the balance of the year.

Encompass Health reported a strong first quarter in 2023, with a 9.5% increase in net operating revenue and a 17.5% growth in Adjusted EBITDA. The company's performance was driven by a 9.4% increase in discharges and substantial improvement in labor costs. Encompass Health also increased its full-year guidance for net operating revenue, Adjusted EBITDA, and adjusted earnings per share.

Encompass Health Corporation reported its Q4 2022 results, with discharge growth of 7.3% and double-digit earnings growth. The company's full-year results reached the top end of its guidance range. Encompass Health issued full-year 2023 guidance.

Encompass Health Corporation reported its Q3 2022 results, demonstrating strong demand for inpatient rehabilitation services with a 7.5% increase in total discharges. However, elevated staffing costs impacted profitability, leading to a revision of the company's 2022 guidance.

Encompass Health Corporation reported its results of operations for the second quarter ended June 30, 2022. Second quarter discharge growth was 4.9%, on top of 18.7% discharge growth in the second quarter of 2021.

Encompass Health reported strong demand for its services in Q1 2022, with revenue growth primarily driven by volume in both the inpatient rehabilitation and home health and hospice segments. The company reaffirmed its full-year 2022 guidance.

Encompass Health's Q3 2021 results showed revenue growth and Adjusted EBITDA increase. The inpatient rehabilitation business experienced strong revenue and Adjusted EBITDA growth, while the home health and hospice business faced COVID-related headwinds. The company lowered its full-year 2021 guidance due to these challenges.

Encompass Health Corporation reported strong second-quarter results, with significant revenue and earnings growth in both segments. The company is raising its full-year 2021 guidance as a result of strong operating trends and year-to-date performance.

Encompass Health Corporation reported its Q1 2021 results with revenue growth resulting from favorable pricing partially offset by decreased volumes in both segments. The company is increasing its 2021 guidance to reflect its strong performance and the extension of the suspension of sequestration.

Encompass Health reported positive results for Q4 2020, demonstrating the resilience of its business model. The company successfully met the needs of patients, employees, and business partners throughout the year, and remains confident in its business and long-term prospects for 2021.

Encompass Health reported its Q3 2020 results, with net operating revenues of $1,173.9 million and adjusted earnings per share of $0.78. The company's volumes recovered substantially, and they remain confident in the longer-term outlook.

Encompass Health reported a decrease in net operating revenues and adjusted earnings per share for the second quarter of 2020 compared to the second quarter of 2019. The company's patient volumes have substantially rebounded from the low point experienced in April.

Encompass Health reported its Q1 2020 results, which were impacted by lower volumes and higher operating expenses related to the COVID-19 pandemic starting in March, although operating performance was strong through February. The company withdrew its 2020 guidance due to rapidly changing operating conditions.

Encompass Health Corporation reported its Q4 2019 results, showing revenue growth driven by volume and pricing in the inpatient rehabilitation segment, and volume growth in the home health and hospice segment. The company had net operating revenues of $1,184.4 million and adjusted earnings per share of $0.85.